FDA Keeps Boxed Warning About Suicide On Chantix
The Food and Drug Administration is keeping a bold-letter warning on Pfizer's anti-smoking drug Chantix about suicidal behavior and other psychiatric side effects, after reviewing company findings suggesting the drug does not increase those problems.



